Insiders who reported open-market trades in the last 12 months at the companies Glenn H. Nussdorf files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Glenn H. Nussdorf is a corporate insider, tracked as Director of Organogenesis Holdings Inc. (ORGO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Glenn H. Nussdorf last file a Form 4?
The most recent primary Form 4 on record is dated 18 December 2025, one of 3 filings going back to 2025.
Has Glenn H. Nussdorf been buying or selling stock?
Recorded transactions: 2 open-market purchases ($1.10M) and 6 open-market sales ($2.70M) across all tracked filings.
Glenn H. Nussdorf is Director of Organogenesis Holdings Inc. (ORGO). 3 SEC Form 4 filings on record, most recently on 18 December 2025. Most recent open-market trade: sold $1.03M of ORGO on 18 December 2025. Lifetime open-market purchases: $1.10M. Lifetime open-market sales: $2.70M.
Recent transactions
8
The latest 8 SEC Form 4 transactions reported by Glenn H. Nussdorf.
InsiderAlpha's records for Glenn H. Nussdorf go back to 2025: 3 primary Form 4 filings, an average of 1.5 per year. The typical open-market purchase is $548K (2 buys totaling $1.10M). The largest single buy on record is $775K of ORGO in 2025. Sales side: 6 recorded sales totaling $2.70M, so the filing history runs sell-heavy by dollar value. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
